Read articles from Global
May 18, 2026 by substack.com
How to Get Less Wrong, Nicotine Edition
Understanding nicotine-related risk requires distinguishing between the harms caused by nicotine itself and those caused primarily by tobacco combustion. Public debate and media coverage often present nicotine as uniformly harmful, despite substantial differences in risk profiles between combustible and non-combustible products. Researchers and harm reduction advocates increasingly argue that inaccurate risk perception may contribute to persistent smoking by discouraging smokers from switching to lower-risk alternatives. Improving public understanding of relative risk remains a central challenge in evidence-based tobacco harm reduction and public health communication.
May 18, 2026 by 2firsts.com
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
The WHO’s first global report on nicotine pouches has intensified debate around the role of non-combustible nicotine products in tobacco harm reduction policy. While the report raises concerns related to youth uptake, product regulation, and long-term health uncertainties, critics argue that the discussion gives insufficient attention to the relative risk differences between nicotine pouches and combustible cigarettes. Researchers and harm reduction advocates continue to emphasize the importance of distinguishing between nicotine use and the harms caused primarily by tobacco combustion. The debate reflects broader disagreements over how public health institutions should balance precautionary regulation with evidence-based approaches to reducing smoking-related disease and mortality.
May 18, 2026 by 2firsts.com
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
The WHO’s first global report on nicotine pouches has intensified debate around the role of non-combustible nicotine products in tobacco harm reduction policy. While the report raises concerns related to youth uptake, product regulation, and long-term health uncertainties, critics argue that the discussion gives insufficient attention to the relative risk differences between nicotine pouches and combustible cigarettes. Researchers and harm reduction advocates continue to emphasize the importance of distinguishing between nicotine use and the harms caused primarily by tobacco combustion. The debate reflects broader disagreements over how public health institutions should balance precautionary regulation with evidence-based approaches to reducing smoking-related disease and mortality.
May 15, 2026 by gfn.tv
GFN.TV Interviews #88 | HOW TOBACCO CONTROL LOST ITS WAY?
Growing criticism of modern tobacco control increasingly centres on concerns that public health policy has shifted away from smoking cessation and toward nicotine prohibition. Critics argue that ideological approaches, misinformation, and the dismissal of harm reduction strategies may be undermining progress in reducing smoking-related disease. The debate also highlights tensions between public health objectives, consumer autonomy, and the role of scientific evidence in shaping regulation of safer nicotine products. As smoking rates continue to decline in many countries, questions are emerging over whether current tobacco control frameworks are adapting effectively to new technologies and evolving patterns of nicotine use.
May 15, 2026 by sciencemediacentre.org
expert reaction to the WHO report on nicotine pouches
Expert reactions to the WHO report on nicotine pouches reflect ongoing divisions within public health and tobacco control research. While concerns continue to focus on youth uptake, nicotine dependence, and product marketing practices, several researchers argue that risk communication should also acknowledge the substantially lower harm profile of non-combustible nicotine products compared with cigarettes. Critics warn that presenting all nicotine products as equally harmful may contribute to growing public misperceptions and discourage smokers from switching away from combustible tobacco. The debate highlights broader tensions between precautionary regulation, harm reduction principles, and the role of scientific evidence in shaping public health policy.
May 15, 2026 by filtermag.org
Three Former WHO Directors Urge It to Back Tobacco Harm Reduction
Growing criticism of the World Health Organization’s position on tobacco harm reduction is now emerging from within its own former leadership. Three former WHO directors argue that achieving major reductions in global smoking prevalence may require greater acceptance of lower-risk nicotine products as part of public health strategy. They warn that excluding harm reduction from tobacco control frameworks could slow progress in reducing smoking-related disease and mortality, particularly in countries where cigarette use remains widespread. The debate reflects broader tensions between abstinence-focused policies and approaches centred on risk reduction, consumer behaviour, and evidence-based regulation.
May 14, 2026 by daily-pouch.com
Another Harm Reduction Journal Paper on How Vaping Helps Beat Smoking
A recent study on e‑cigarette use and smoking cessation found that using nicotine vapes with support increases quitting success by 2-3 times compared to support alone. Vaping also led to a reduction of 4–5 cigarettes per day. Results varied on whether vapes were more effective than traditional stop‑smoking medicines. Consistent vape usage was crucial for quitting success. High-quality studies confirmed vaping as an effective quit aid, but long-term data and evolving vape products pose some concerns. Overall, the study highlights the importance of integrating vapes into smoking cessation programs and addressing the stigma around their use.
May 14, 2026 by substack.com
Two Americas of FDA Tobacco Regulation
Navigating the complex PMTA process involves years of compiling applications, paying for legal and compliance costs while facing state and local restrictions. Despite declining smoking rates, concerns arise over FDA authorizations, especially in cases like GLAS. Large tobacco companies invest billions in expansions, hinting at foreknowledge of regulatory outcomes. Small businesses are left waiting, contrasting with big corporations' bold moves. Doubts about regulatory coherence lead to skepticism, as concerns about regulatory personnel transitions and industry ties emerge. Uncertainty prevails for small businesses awaiting decisions, while larger corporations seem assured. The system's mixed messages raise questions about fairness and predictability in public health regulation.
May 14, 2026 by dcjournal.com
Survey Findings That Anti-Nicotine Groups Don’t Want You to Know
Recent survey findings suggest that public attitudes toward nicotine and tobacco policy may be more complex than commonly reflected in advocacy campaigns and media narratives. The data indicate that many smokers feel increasingly stigmatised and disconnected from public health messaging, particularly when harm reduction approaches are excluded from policy discussions. Researchers and analysts argue that overlooking the perspectives and behavioural realities of smokers may limit the effectiveness of tobacco control strategies aimed at reducing combustible cigarette use. The findings also reinforce ongoing debates about the role of consumer choice, risk communication, and access to lower-risk alternatives within evidence-based public health policy.
May 13, 2026 by substack.com
Lies and damned lies
Debates around tobacco harm reduction are increasingly exposing tensions between public health messaging and institutional behaviour. Critics argue that some organisations continue to reject lower-risk nicotine alternatives while simultaneously supporting policies that have failed to reduce smoking effectively. The discussion highlights what is seen as a growing disconnect between scientific evidence, consumer experiences and regulatory narratives. Concerns are also raised about selective framing of risk, particularly when safer alternatives are treated similarly to combustible cigarettes. At the centre of the debate lies a broader question of consistency, credibility and whether public health policies are being applied evenly across different forms of nicotine use.